User profiles for David A. Henry

David Henry

Honorary, Bond University, UNSW and UMelbourne, Australia; Emeritus, ICES and …
Verified email at bond.edu.au
Cited by 67539

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

…, P Tugwell, V Welch, E Kristjansson, DA Henry - bmj, 2017 - bmj.com
The number of published systematic reviews of studies of healthcare interventions has
increased rapidly and these are used extensively for clinical and policy decisions. Systematic …

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

…, E Kristjansson, J Grimshaw, DA Henry… - Journal of clinical …, 2009 - Elsevier
OBJECTIVE: Our purpose was to measure the agreement, reliability, construct validity, and
feasibility of a measurement tool to assess systematic reviews (AMSTAR). STUDY DESIGN …

Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion

DA Henry, PA Carless, AJ Moxey… - Cochrane database …, 2011 - cochranelibrary.com
Background Concerns regarding the safety of transfused blood have led to the development
of a range of interventions to minimise blood loss during major surgery. Anti‐fibrinolytic …

[HTML][HTML] A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

…, DT Ko, PE Szmitko, PC Austin, JV Tu, DA Henry… - Cmaj, 2009 - Can Med Assoc
Background: Most proton pump inhibitors inhibit the bioactivation of clopidogrel to its active
metabolite. The clinical significance of this drug interaction is unknown. Methods: We …

[PDF][PDF] Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast …

DH Henry, L Costa, F Goldwasser, V Hirsh, V Hungria… - J Clin Oncol, 2011 - eclass.uoa.gr
Purpose This study compared denosumab, a fully human monoclonal anti-receptor activator
of nuclear factor kappa-B ligand antibody, with zoledronic acid (ZA) for delaying or …

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

…, JF Viallard, FJ Cuevas, RS Go, DH Henry… - The Lancet, 2008 - thelancet.com
Background Chronic immune thrombocytopenic purpura (ITP) is characterised by accelerated
platelet destruction and decreased platelet production. Short-term administration of the …

Cell salvage for minimising perioperative allogeneic blood transfusion

PA Carless, DA Henry, AJ Moxey… - Cochrane database …, 2010 - cochranelibrary.com
Background Concerns regarding the safety of transfused blood have prompted reconsideration
of the use of allogeneic (from an unrelated donor) red blood cell (RBC) transfusion, and …

Exposure to community violence and violence perpetration: The protective effects of family functioning

D Gorman-Smith, DB Henry… - Journal of Clinical Child …, 2004 - Taylor & Francis
Although research has found that urban youth are exposed to excessive levels of community
violence, few studies have focused on the factors that alter the risk of exposure to violence …

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III …

…, C Du Mond, RD Mamelok, DH Henry - Journal of clinical …, 1998 - ascopubs.org
PURPOSE Kaposi's sarcoma (KS), the most common neoplasm in patients with AIDS, is a
significant clinical problem for which current therapies are frequently unsatisfactory. We …

[HTML][HTML] Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials

A Lipton, K Fizazi, AT Stopeck, DH Henry… - European journal of …, 2012 - Elsevier
BACKGROUND: Patients with bone metastases from advanced cancer often experience
skeletal-related events (SRE), which cause substantial pain and morbidity. Denosumab, a fully …